Biofourmis

Boston, Massachusetts, United States All United States companies → — Founded 2015

Clinical AI Platform Telehealth Network Wearables / RPM

Series D

Website Claim this company

Products

Biovitals Analytics Engine

Biofourmis

Triage & ER/ICU AI

The Biovitals™ Analytics Engine is an AI-powered platform that analyzes continuous physiological data from wearable biosensors to predict clinical exacerbations, enabling early intervention and personalized care.

See all 1 product →

About Biofourmis

Biofourmis is a global health technology company that utilizes an AI-driven platform to deliver advanced, technology-enabled care solutions and clinical support. For physicians, Biofourmis offers a connected platform designed to improve patient outcomes, prevent hospital readmissions, and accelerate drug development. The platform collects and analyzes over 120 biomarkers in real time, identifying shifts that may require proactive interventions. This enables the delivery of hospital-level services and virtual provider networks for remote care, as well as facilitating clinical trials, all within the patient’s home.

The company’s solutions are trusted by health systems, payers, and biopharma companies, aiming to make science smarter, healthcare simpler, and patients healthier by closing critical gaps in care. Biofourmis’s Biovitals Platform and its library of biomarkers are designed to predict clinical complications and provide personalized care for patient populations at home across the care continuum. The predictive analytics offer clinicians real-time, personalized data and notifications to detect signs of potential clinical deterioration, allowing for earlier intervention to enhance patient safety, improve outcomes, and reduce costs. Their offerings include “Hospital at Home” programs, timely discharge solutions, and skilled nursing facility (SNF) care at home, all supported by continuous and episodic monitoring, AI-enabled analytics, and coordinated in-home services. Biofourmis also provides remote patient management with personalized care plans and patient engagement tools to help prevent post-discharge decompensation and reduce re-hospitalizations.

Focus Areas

virtual care digital therapeutics remote patient monitoring AI-powered analytics chronic disease management post-acute care medication adherence

Business Intelligence

Technology

AI-powered digital health platform, cloud-native, real-time physiological data integration, predictive analytics

What Physicians Need to Know

Virtual Care & Remote Patient Monitoring

Biofourmis offers a comprehensive virtual care platform that includes Hospital@Home for acute conditions, remote patient management for post-discharge care, and virtual specialty care for chronic disease management. They utilize wearable sensors to continuously monitor patients' physiological data, enabling virtual care teams to track vital signs, detect anomalies, and intervene proactively. This approach has shown a 70% reduction in 30-day readmissions and the ability to detect deterioration 21 hours sooner.

Digital Therapeutics

Biofourmis develops clinically validated software-based therapeutics, often in partnership with pharmaceutical companies, to augment personalized care and improve the management of complex chronic conditions. Their BiovitalsHF® platform, for example, received FDA breakthrough device designation for heart failure medication monitoring, streamlining the titration process by analyzing wearable data and patient-reported outcomes.

AI-Powered Analytics

At the core of Biofourmis' offerings is their AI-driven predictive analytics engine, Biovitals. This technology collects and analyzes over 120 biomarkers in real-time, identifies shifts that require proactive interventions, and can predict clinical deterioration early. The AI algorithms can also assist with medication optimization, providing recommendations to clinical teams based on vital signs, medical history, and symptoms.

Chronic Disease Management

Biofourmis Care provides virtual chronic condition management for conditions such as heart failure, diabetes, hypertension, atrial fibrillation, and lipid management. Their platform can co-manage multiple chronic diseases simultaneously and tailor the intensity of services to match illness severity. Virtual care teams work with existing providers to improve medication and treatment adherence.

Post-Acute Care

The platform supports remote patient management for post-discharge care, aiming to reduce hospital readmissions. This includes continuous monitoring and coordination of in-home services.

Medication Adherence

Biofourmis utilizes sophisticated software algorithms for medication optimization, assisting care teams in remotely adjusting medications for personalized therapy. The patient app also includes medication reminders.

Key Differentiators

Biofourmis stands out due to its FDA-cleared AI-driven algorithms that create personalized baselines for each patient and detect clinically significant deviations, enabling early prediction of deterioration. Their platform is device-agnostic, allowing integration with various medical-grade sensors and existing systems. They offer a comprehensive care continuum, from acute hospital-at-home to chronic disease management, supported by a multidisciplinary virtual care team.

Technology Stack

While specific details are proprietary, Biofourmis leverages a cloud-based infrastructure with robust data science capabilities. Their technology stack includes HubSpot Analytics, Chef Infra, AWS Data Pipeline, Microsoft SQL Server, and AirWatch.

Physician Tip

For physicians, Biofourmis offers a powerful extension of their care team, providing continuous, real-time patient data and AI-driven insights that can lead to earlier interventions and improved outcomes. The platform's ability to co-manage multiple chronic conditions, provide automated medication management recommendations, and integrate with existing EHR systems (like Epic and Cerner) streamlines workflows and reduces clinician burden. The personalized predictive analytics help in identifying at-risk patients before acute events, allowing for proactive care adjustments and potentially reducing hospital readmissions. The virtual care teams, including health navigators, nurses, and advanced practice providers, partner with on-the-ground primary and specialty care providers to ensure seamless care coordination.

Biofourmis' platform is designed for interoperability and integrates with Electronic Health Record (EHR) systems such as Epic and Cerner, ensuring seamless data flow and care coordination. It is also device-agnostic, allowing for flexible integration with a wide range of medical-grade clinical devices and sensors.

At a glance

Founded 2015

HQ Boston, Massachusetts, United States · United States

CEO David Koretz

Funding Series D

Products 1

Visit site

Products by Biofourmis

1 product in the directory

Biovitals Analytics Engine

Biofourmis

Triage & ER/ICU AI

What the Web Says

Biofourmis generally receives positive reviews for its AI-powered remote patient monitoring and digital therapeutics platform, which aims to improve patient outcomes and reduce hospital readmissions. The company is recognized for its innovative technology and mission to transform healthcare. Employee reviews are largely positive, highlighting a great company mission and supportive colleagues, though some concerns exist regarding executive leadership and past layoffs.

Overall: Mixed

Strengths

AI-driven solution for real-time patient data analysis and proactive interventions.
Proven clinical outcomes, including reduced hospital readmissions and earlier interventions.
Comprehensive platform with 120+ biomarker real-time analysis.
Strong company mission and a sense of pride among employees for contributing to digital healthcare.
Competitive compensation and benefits for employees.
Flexible and inclusive work environment with opportunities for growth.

Limitations

Enterprise-only pricing with no public information or options for small businesses/individual clinicians.
Implementation can be complex, requiring EHR integration and clinical workflow setup.
Some employee dissatisfaction with executive leadership and communication regarding layoffs.
Not currently set up well to support employees without experience, needing improvement in onboarding and growth plans.
Primarily US-focused deployment despite a global presence.
Traction signals and community usage visibility are still modest, suggesting a need for more widespread adoption.

Based on reviews from: Comparably, Indeed.com, Elion Health, AI Central Resources, Aiinity, Biofourmis Website

Last updated: 2026-10-21

Videos

News, demos, and interviews about Biofourmis.

Loading videos...

Videos load interactively. If none appear, search YouTube for Biofourmis →

View all on YouTube

Press & Coverage

PR Newswire

Biofourmis Expands Access to Care and Streamlines Workflows with Integrated On-Demand In-Home Services Ecosystem

Biofourmis launched its in-home services solution to expand access to care and streamline workflows, providing a comprehensive ecosystem for technology-enabled care delivery.

2024-01

Biofourmis (via PR Newswire)

Biofourmis Secures Four New Agreements with Top-20 Pharma on Strength of Platform for Digital Clinical Trials and Digital Biomarkers

Biofourmis announced four new agreements with top pharmaceutical companies, leveraging its expertise in digital biomarker development and comprehensive clinical trial solutions.

2024-02

Biofourmis

Community Health Network Selects Biofourmis to Help Drive Care-at-Home Outcomes Across the Continuum

Community Health Network selected Biofourmis to enhance and expand its care-at-home services, integrating virtual and in-person care with data-driven insights to improve patient monitoring and reduce hospital readmissions.

2024-04

Biofourmis

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

GE HealthCare and Biofourmis are collaborating to support patients across the care continuum, facilitating transitions and care from hospital to home through virtual care-at-home solutions.

2024-02

Biofourmis

Biofourmis Unveils Digital Measure for Nocturnal Scratch and Sleep Quality in Atopic Dermatitis

Biofourmis introduced a new digital measure using wearable sensors and machine learning to objectively monitor nocturnal scratching and sleep quality in atopic dermatitis patients, aiding drug development and improving outcomes.

2024-09

Business Wire

CopilotIQ and Biofourmis Merge to Create the First End-to-End Platform for AI-Driven In-Home Care

CopilotIQ and Biofourmis merged to establish a comprehensive platform for AI-driven in-home care, covering pre-surgery, acute, post-acute, and chronic care.

2024-10

Business Wire

Biofourmis Supports Expansion of Remote Patient Monitoring and Introduction of Home Based Hospital Care at Lee Health

Biofourmis is partnering with Lee Health to expand its remote patient monitoring services and launch a new Hospital at Home program, the first of its kind in Southwest Florida.

2024-11

PR Newswire

Biofourmis Accelerates and Simplifies Drug Development with Expanded Digital Clinical Trials Solution

Biofourmis released an expanded Digital Clinical Trials solution to accelerate and simplify drug development for biopharma and life sciences companies.

2023-09

Frequently Asked Questions

What specific virtual care and remote patient monitoring solutions does Biofourmis offer for chronic disease management and post-acute care?

Biofourmis provides a comprehensive virtual care platform that integrates remote patient monitoring (RPM) with AI-powered analytics to manage chronic conditions like heart failure and diabetes, as well as support post-acute care transitions. Their solutions leverage wearable sensors and patient-reported data to provide continuous physiological monitoring and early detection of deterioration, enabling timely interventions.

How do Biofourmis's AI-powered analytics improve patient outcomes and operational efficiency in a clinical setting?

Biofourmis's AI-powered analytics synthesize data from various sources, including RPM devices and electronic health records, to generate personalized insights and predictive analytics. This helps clinicians identify at-risk patients, optimize treatment plans, and proactively intervene, ultimately leading to improved patient outcomes and more efficient resource utilization.

What digital therapeutics and medication adherence programs does Biofourmis offer, and how do they address compliance concerns?

Biofourmis offers digital therapeutics that combine personalized coaching, education, and behavioral nudges to improve medication adherence and self-management of chronic conditions. Their platform provides reminders, tracks medication intake, and offers insights into adherence patterns, helping to address compliance concerns and empower patients in their treatment journey.

Can you provide information on Biofourmis's pricing structure, implementation process, and the level of support provided to healthcare organizations?

Biofourmis typically offers flexible pricing models tailored to the specific needs and scale of healthcare organizations, often based on per-patient per-month fees or value-based agreements. Their implementation process involves a dedicated team that assists with integration into existing workflows, and they provide ongoing technical support, training, and clinical guidance to ensure successful adoption and utilization.

What partnerships does Biofourmis have with other healthcare providers, technology companies, or payers, and what is the company's overall stability and future outlook?

Biofourmis has established strategic partnerships with leading healthcare systems, pharmaceutical companies, and payers to expand its reach and enhance its offerings. The company has demonstrated strong growth and secured significant funding rounds, indicating a stable financial position and a positive outlook for continued innovation and market expansion in the virtual care and digital therapeutics space.